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ABSTRACT Convection-enhanced delivery (CED) is a pro-
mis ing technique leveraging pressure-driven flow to incr-
ease penetration of infused drugs into interstitial spaces. 
We have developed a fiberoptic microneedle device for 
inducing local sub-lethal hyperthermia to further improve 
CED drug distribution volumes, and this study seeks to 
quantitatively characterize this approach in agarose tissue 
phantoms. Infusions of dye were conducted in 0.6% (w/w) 
agarose tissue phantoms with isothermal conditions at 
15 °C, 20 °C, 25 °C, and 30 °C. Infusion metrics were 
quantiﬁ ed using a custom shadowgraphy setup and image-
processing algorithm. These data were used to build an 
empirical predictive temporal model of distribution volume as 
a function of phantom temperature. A second set of proof-
of-concept experiments was conducted to evaluate a novel 
fiberoptic device capable of generating local photothermal 
heating during ﬂ uid infusion. The isothermal infusions showed 
a positive correlation between temperature and distribution 
volume, with the volume at 30 °C showing a 7-fold increase 
at 100 min over the 15 °C isothermal case. Infusions during 
photothermal heating (1064 nm at 500 mW) showed a similar 
eﬀ ect with a 3.5-fold increase at 4 h over the control (0 mW). 
These results and analyses serve to provide insight into and 
characterization of heat-mediated enhancement of volumetric 
dispersal. 
KEYWORDS near-infrared laser, thermochemotherapy, agar-
ose, photothermal heating, micro-catheter, malignant glioma
1 Background and objectives
Many novel approaches have been developed to circumvent 
the blood-brain barrier and deliver pharmaceuticals to intra-
cerebral targets [1–5]. Convection-enhanced delivery (CED) 
is a promising technique that avoids this issue through us-
ing catheters to infuse drugs locally within intracerebral 
targets [6–8]. To accomplish this, one or more catheters are 
inserted through a burr-hole in the skull and advanced to 
a target site. Once placed, a gradual, continuous infusion is 
maintained to provide pressure-driven ﬂ ow for the infusate 
of interest. CED approaches have been developed for treating 
neurodegenerative, epileptiform, and neoplastic maladies [7, 
9–13]. Due to pressure limitations on feasible infusion rates, 
CED is frequently maintained at a slow rate for up to several 
days. Often compared to biodegradable polymer delivery 
systems, CED has been demonstrated to increase effective 
tissue penetration of infused drugs by over an order of mag-
nitude relative to diffusion-based methods without causing 
cerebral edema [14, 15]. The method is particularly attractive 
for delivering larger molecules that cannot bypass the blood-
brain barrier and have lower effective rates of diffusion, such 
as antibodies, chemotherapeutics, and immunotoxins [16–21]. 
Unfortunately, the PRECISE study, the ﬁ rst multi-center trial 
utilizing CED to treat malignant glioma, did not meet re-
quired minimum clinical outcomes. In a retrospective analy-
sis by Sampson et al., this failure was attributed to CED not 
achieving sufficient dissemination of the chemotherapeutic 
immunotoxin throughout malignant volumes and the sur-
rounding margins [22]. Despite these discouraging results, 
many groups still seek better strategies and solutions to le-
verage CED into a viable clinical tool. 
Another strategy for enhancing the penetration of infused 
chemotherapeutic agents is thermochemotherapy, as heating 
of the drug solution has been shown to substantially increase 
the effective depth of treatment [23]. In addition, adjunc-
tive hyperthermia has been demonstrated to significantly 
increase the cytotoxic capacity of many chemotherapeutic 
agents [24–26]. DeWitt et al. demonstrated that mild hyper-
Research
345
Medical Instrumentation—Article Research
www.engineering.org.cn  Volume 1 · Issue 3 · September 2015  Engineering
thermia could also increase the drug uptake into the cell, 
which was attributed to plasma membrane permeabiliza-
tion [27]. This group has developed a technological solution 
enabling a combination of thermochemotherapy with in-
tracranial CED via a novel ﬁ beroptic catheter, the ﬁ beroptic 
microneedle device (FMD), which enables co-delivery of 
ﬂ uid agents and laser energy. This design and its fabrication 
methods have been described previously [28], as have charac-
terizations of its mechanical penetration, light-guidance, and 
fluid delivery [28–31]. This group previously demonstrated 
that photothermal heating at the point of infusion could 
increase volumetric dispersal of contrast agents delivered 
through CED within an in vivo rodent model [28].
This study sought to determine if the volumetric disper-
sal enhancement seen in rodent models was also observed 
in agarose phantoms and, if so, to begin characterizing the 
heat-mediated dispersal increase. Agarose tissue phantoms 
at a weight ratio of 0.6% are an accepted simulacrum of ce-
rebral tissue [32, 33] and allow direct observation of infused 
volumes. Initial experiments mimicked our previous in vivo 
approaches through delivering contrast agents into agarose 
with concurrent photothermal heating. To better quantify 
thermal effects, additional experiments characterized infu-
sions into agarose volumes heated at near-isothermal condi-
tions via waterbath, removing the anisotropic photothermal 
heating element. These experiments utilized a simplified 
catheter prototype using a non-light-guiding silica capil-
lary of identical dimensions to our co-delivery FMD design 
(365 µm in outer diameter (OD); 150 µm in inner diameter 
(ID)). Further analysis focused on characterizing the heat-
mediated changes to dispersal of infused contrast agents. 
2 Materials and methods
2.1 Fiberoptic microneedle device designs
To determine if agarose exhibited a heat-mediated increase 
in volumetric disposal, an experiment was conducted with a 
two-ﬁ ber FMD design. FMD catheters were created through 
bonding fused silica capillary tubing (150 μm/365 μm ID/
OD, Polymicro Technologies, Phoenix, AZ, USA) along the 
length of a multimode fiberoptic (100 µm/110 µm/125 µm 
core/cladding/buffer, numerical aperture (NA) = 0.22, Poly-
micro Technologies, Phoenix, AZ, USA). A nested syringe-
needle system was necessary to allow ﬂ uid coupling into the 
capillary without running the fiberoptic through the fluid 
line. One end of the capillary was epoxied into the tip of a 
22G dispensing needle, while the infusing length extended 
~ 10 cm beyond the needle. This setup enabled ﬂ uid coupling 
via the dispensing needle’s Luer-Lock. The capillary and 22G 
needles were threaded alongside the ﬁ beroptic into a second-
ary 18G needle that acted as a housing. The endfaces of the 
fiberoptic and capillary co-terminated 2.5 cm from the tip 
of the 18G housing. Following immobilization of the glass 
ﬁ bers, the housing was ﬁ lled with epoxy to promote lateral 
stability. This assembly is depicted in Figure 1. 
A simpliﬁ ed FMD prototype was employed for isothermal 
agarose infusions with the goal of simplifying the heating pro-
ﬁ le to better characterize the heat-mediated transport. These 
FMDs were fabricated through adhering fused silica capillary 
tubing within a 1 in (1 in = 2.54 cm), 22G, stainless-steel dis-
pensing needle (McMaster-Carr, Atlanta, GA, USA). The capil-
lary tubing was cut to 3.75 cm in length and adhered within the 
dispensing needle so that the capillary extended 2.5 cm from 
the blunt end of the dispensing needle. This assembly is shown 
in Figure 2. The Luer-Lock ﬂ uid couple at the proximal end of 
the dispensing needle allowed attachment to the ﬂ uid system.
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Figure 1. (a) Depiction of FMD design; (b) experimental setup. 
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Figure 2. (a) The FMD assembly made from a 22G needle and a length of 
silica capillary, with an inset showing the tip; (b) a diagram of the experimental 
setup: The diagram is simpliﬁ ed to a single needle, although actual experiments 
were done with three needles in parallel (into the page from this perspective) 
delivering simultaneously. DAQ stands for data acquisition unit.
2.2 Co-delivery into agarose
The proof-of-concept co-delivery infusions with the two-ﬁ ber 
FMDs were conducted within rectangular, polystyrene molds 
(1.7 cm × 8.1 cm × 3.9 cm) open at the top. An agarose (certi-
ﬁ ed molecular biology grade, Bio-Rad Laboratories, Hercules, 
CA, USA) solution was mixed at 0.6% (w/w) with de-ionized 
water, boiled, and decanted into the molds after a brief cool-
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ing period. The molds were wrapped in parafﬁ n wax and re-
frigerated at 4 °C overnight prior to use. For the experiment, 
the agarose was removed from refrigeration and allowed to 
return to room temperature. Appropriate warming was es-
tablished through measurement with a T-type thermocouple 
and a HH127 Data Logger (Omega Engineering, Stamford, 
CT, USA).
A custom shadowgraphy framework was used as previ-
ously described [34]. Briefly, a light-diffusing acrylic sheet 
was mounted in an aluminum window. An attached mi-
crometer (OptoSigma, Santa Ana, CA, USA) allowed the 
precision-controlled insertion of FMD catheters. The frame-
work enabled backlit visualization of the infused volume 
and vertical, guided insertion of the two-ﬁ ber FMD into the 
agarose volumes. A schematic of this setup is shown in Fig-
ure 1. Infusions into agarose were conducted at a flow rate 
of 1 µL· min–1. Laser irradiation was provided by a 1064 nm 
CW diode-pumped ﬁ ber laser (IPG Photonics, Oxford, MA, 
USA). A laser power of 500 mW was determined to heat the 
agarose volume to a steady-state increase in temperature of 
4–5 °C within a two-hour period in preliminary experiments 
(data not shown). A free space-to-ﬁ beroptic coupler (Newport 
Corporation, Irvine, CA, USA) was utilized for coupling light 
into the FMD’s multimode ﬁ beroptic. The coupling efﬁ ciency 
was established prior to every insertion with an integrating 
sphere (Newport Corporation, Irvine, CA, USA). The capil-
lary tube was connected via a micro-IV extension set to a 
10 mL syringe (containing 5% FD&C Blue #2) actuated by a 
PHD Ultra syringe pump (Harvard Apparatus, Holliston, 
MA, USA). 
The FMD was rapidly inserted into the agarose manually, 
guided by the micrometer’s rails. Rapid catheter insertion has 
been demonstrated to reduce backﬂ ow by quickly overcom-
ing the viscoelastic compression of the media [35]. Following 
manual insertion approximately 1.25 cm within the agarose, 
the micrometer was used to precisely place the tip 1.5 cm 
from the surface. Finally, the catheter tip was raised by 1 mm, 
which was shown by Martanto et al. to aid in removing any 
coring of the agarose into the capillary [36].  
Following successful insertion, ﬂ uid infusion at 1 µL· min–1 
and laser irradiation at a delivery of 500 mW were begun 
simultaneously. Photographs were automatically captured 
once per minute from an angle perpendicular to the cath-
eter’s body through the transparent polystyrene mold and 
agarose. An OPP-M fiberoptic sensor (OpSens Inc., Québec 
City, Québec, Canada) monitored the line pressure at the sy-
ringe pump. If line pressure reached 40 mmHg (1 mmHg ≈ 
1.33 × 102 Pa), the system was considered clogged and the tip 
was raised and lowered 1 mm by the micrometer to alleviate 
any coring within the catheter’s tip. Infusion was ceased and 
all data discarded if line pressure reached 60 mmHg or dye 
dispersal contacted the polystyrene mold surface. 
2.3 Isothermal agarose infusions
A custom infusion setup was designed for conducting aga-
rose infusions in waterbaths to provide a repeatable, near-
isothermal environment. T75 flasks (Corning Inc., Corning, 
NY, USA) were modiﬁ ed by drilling four ports into the nar-
row side of the container: three for FMD insertion and one 
for a micro-thermocouple (Omega Engineering, Stamford, 
CT, USA). To better isolate thermal effects from disturbance 
of the agarose during insertion, the FMDs were cast within 
the agarose. Three FMDs were pressed ﬁ rmly into the drilled 
ports of each ﬂ ask and epoxied into place. Each FMD had a 
polyimide-jacketed fused-silica ﬁ ber (125 µm in OD) inserted 
through its hollow bore to exclude liquid agarose rising into 
the tube through capillarity during the cure process. A plug 
of removable hot glue was used to temporarily seal the ther-
mocouple port. Three-way T-couples were attached to the 
Luer-Lock connector of each 22G needle. The fiberoptics 
passed through the T-couple and extended beyond the top. 
This assembly provided a submersible housing for the aga-
rose volume. The agarose was prepared and decanted into 
T75 flasks as described above. The flasks were capped and 
placed on their sides (T-couples facing upwards) in 4 °C re-
frigeration for at least 24 h prior to use. A small amount of 
de-ionized water was injected through each T-couple and left 
within the T-couple/FMD to exclude air during the cure pro-
cess. 
Once the agarose had set, the flasks were removed from 
refrigeration. The fused silica ﬁ bers were carefully removed 
from the FMDs. Syringes (3 mL in BD) secured within a sy-
ringe pump (Harvard Apparatus, Holliston, MA, USA) were 
coupled individually to each T-couple on the ﬂ ask via micro-
IV extension (Smiths Medical ASD, Inc., Dublin, OH, USA) 
lines. Both the syringes and extension sets were filled with 
5% (w/w) FD&C Blue #2 dye prior to connection with the 
FMDs. The dye was allowed to diffuse freely throughout 
the de-ionized water within the T-couple, which did not di-
lute the dye sufﬁ ciently to interfere with the shadowgraphic 
measurements. The hot glue over the thermocouple port was 
carefully removed and a T-type micro-thermocouple was 
inserted into the agarose. A large, transparent, plastic vessel 
served to contain the waterbath. The agarose-ﬁ lled T75 ﬂ ask 
and connected fluid lines were gently placed into the bath. 
The bath temperature was regulated by a water heater/chiller 
(ThermoNeslab RTE 7 Chiller, Newington, NH, USA). Near-
isothermal environments were maintained at four different 
experimental temperatures: 15 °C, 20 °C, 25 °C, and 30 °C. T-
type thermocouples were placed within the free ﬂ uid of the 
waterbath and an exterior beaker of ice water, which served 
as a cold junction for calibration. All T-type thermocouple 
measurements were recorded on a HH127 Data Logger (Ome-
ga Engineering Inc., Stamford, CT, USA). 
Once the target isothermal environment was achieved, 
the syringe pump was activated to provide an infusion rate 
of 1 µL· min–1 for 100 min. Temperatures within the agarose 
were maintained within ± 2 °C of their target or the infusion 
set was discarded. Line pressure for each infusion was moni-
tored with wet/wet differential pressure sensors (Omega En-
gineering Inc., Stamford, CT, USA) connected in parallel with 
the micro-IV extension lines via the T-couples. The sensors 
were controlled by an eight-channel data-acquisition unit 
(Omega Engineering Inc., Stamford, CT, USA) connected to a 
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laptop. A schematic of the experimen-
tal setup is provided in Figure 2. The 
experimental setup was backlit with 
a bright lamp, allowing contrast shad-
owgraphy measurements to be taken 
through photographing the contralat-
eral side of the agarose volume. Pho-
tographs were automatically captured 
once per minute by a Canon EOS Rebel 
T1i/EOS 500D camera (Canon USA, 
Lake Success, NY, USA). 
2.4 Poroelastic model
A model developed by Chen et al. was 
modified and fit to the data in order 
to capture the temperature dependent 
effect on volumetric dispersal rate 
[37]. Their study focused on modeling 
volumetric distribution as a function of 
infusion rate, whereas the isothermal 
experiments in this study sought to 
determine volumetric distribution as 
a function of temperature. Beginning 
with volume continuity and a modiﬁ ed 
Darcy’s law describing the poroelastic 
case, Chen et al. developed a descrip-
tion of volume of distribution (Vd) as 
a function of pore fraction (φ), dilata-
tion (e), and time (t). The deformation 
behavior of the agarose’s porous frame 
was captured by modifying the equa-
tions that describe convective transport 
through rigid porous media. The dila-
tational diffusion constant (Dd) is de-
fined as, which includes contributions 
from the Darcy permeability of the 
agarose (k) as well as the material rigid-
ity (λ) and compressibility (μ), moduli. 
If steady-state (where t >> r2/Dd) is as-
sumed, the transient contributions of 
the agarose’s rigidity and compressibil-
ity can be ignored. This allows the pore 
fraction to be written as a function of 
radius:
          
 ( ) 0, A rr t
A r
ϕ
ϕ
+
≈
+    
 (1)
where A is defined as A = q/(4πDd), in 
which q is the volumetric flow rate; φ0 
is the initial pore fraction (t = 0); r is the 
radius. If the volume, after a very long 
time frame, is equal to the total infused 
volume (Vinf = qt), the radius R of the 
resulting volume of distribution within 
the agarose can be calculated by the 
equation:
        ( )
0
2
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R
r
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As agarose is a viscoelastic medium, 
its material properties vary with tem p erature. These contributions are captured 
within the Dd parameter, although decoupling the inﬂ uences of Darcy permeability 
and the material moduli was not possible with this experimental approach. In this 
experiment, we were able to directly calculate Vd as a function of time and tempera-
ture. This was achieved through algorithmic post-processing of infusions over a 
series of time-sequence images. Following the precedent set by Chen et al. of ana-
lyzing volumetric dispersal at 100 min, we calculated Dd(T ) at 100 min through its 
relation to Vd(T ) and applied an exponential regression to describe the distribution:
    
                                                     ( )d 100 min bTtD T ae= =       (3)
where a and b are constants equaling 5.739 × 10–8 and –0.05678, respectively. By ap-
plying this regression to Eq. (2), one can describe a relationship between R(T )3 and 
Dd(T ), which allows direct prediction of Vd(T ) as 
                                                   ( ) ( )3d 3
4 πV T R T=    (4)
This relation for Dd as a function of temperature provides a steady-state, empiri-
cal prediction of the temperature dependent volumetric dispersal that should be 
adaptable to other agarose models or even as a component of the distribution with-
in living tissue.   
3 Results
3.1 Co-delivery agarose infusions
Volumetric dispersal in the co-delivery infusion experiments was calculated once 
per minute through analysis of captured photographs. This group has previously 
demonstrated that this method has an associated error of less than 5% [34]. This 
data is shown in Figure 3(a). Each curve represents an average of N = 5 experi-
ments. Exclusion criteria included dye-front contact with the agarose boundar-
ies, temperature variation of > ± 2 °C of the target, and line pressure exceeding 
60 mmHg. Co-delivery exhibited a substantially enhanced volumetric dispersal 
relative to infusion-only controls. Analysis of the distance of forward distribution 
from the catheter’s tip for every frame is provided in Figure 3(b). Co-delivery was 
associated with signiﬁ cantly enhanced forward progress of the dye. However, as 
the photothermal heating was highly anisotropic and nontrivial to measure or esti-
mate, experiments utilizing uniformly heated agarose volumes were conducted to 
better establish the relationship between temperature and volumetric dispersal. 
3.2 Isothermal agarose experiment results
At least N = 4 experiments for each temperature were included in the volume dis-
tribution analysis. Volumetric dispersal rate positively correlated with increasing 
temperature, and the 100 min average of Vd at 30 °C was over 7-fold greater than the 
15 °C average at the same time point. Figure 4 provides a plot of the volume distri-
bution as a function of time for each temperature as well as representative images 
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Figure 3. (a) Data from the co-delivery experiment exhibiting the volumetric dispersal; (b) the forward dye 
progression for the 500 mW irradiation and infusion-only groups. Error bars depict two standard deviations. 
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Figure 4. (a) Volume distributed versus time for each experimental temperature; (b) representative images of isothermal infusions at 15 °C (left) and 30 °C (right) 
after 100 min.
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from the 15 °C and 30 °C experiments 
at 100 min.
Line pressure averaged (29.1 ± 11.0) 
mmHg, (29.3 ± 6.8) mmHg, (20.5 ± 
1.0) mmHg, and (29.7 ± 5.6) mmHg for 
the 15 °C, 20 °C, 25 °C, and 30 °C sets, 
respectively. These results suggested 
that volumetric flow rate had no de-
pendence on line pressure; although it 
should be noted that line pressure may 
not be indicative of pressure within the 
diffusing dye volume. To determine 
statistical significance and provide a 
time point for the theoretical analysis 
described below, the volume at 100 min 
was chosen as a comparison point be-
tween the different populations. Figure 
5 shows a bar plot of the distributed 
volume for each temperature at 100 
min. A student t-test showed each of 
the populations to be statistically dif-
ferent at P < 0.05. The lack of correlation 
between standard deviations shown for 
each group and for respective line pres-
sures provides further evidence of the 
independence of volumetric dispersal 
from line pressure. 
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regression; (b) measured volume distribution values as a function of temperature at 100 minutes plotted with 
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3.3 Model development
Chen et al. estimated values for the different constants by employing a simulta-
neous least-squares procedure on a cost-function involving their measured and 
predicted pressure and distribution volume data [38]. This group used the empiri-
cally derived constants from Chen et al. and experimentally measured Vd values 
to describe the dilatation diffusion constant Dd at each agarose temperature. An 
exponential regression was determined to provide the best ﬁ t at most volumetric 
dispersal time points through R2 value comparison between quadratic, exponen-
tial, and power law regressions in MATLAB. This regression enabled a theoretical 
prediction for volume distribution as a function of temperature. Figure 6 shows a 
plot of the experimental data after 100 min of infusion and the theoretical predic-
tion. 
4 Discussion
The isothermal experiments sought to quantify the relationship between the rate 
of volume increase and the temperature of the agarose. Experiments at 15 ºC, 20 ºC, 
25 ºC, and 30 ºC demonstrated a positive correlation between increased tempera-
ture and volumetric dispersal. Analysis of these data showed that the 30 ºC average 
at 100 min was over seven times greater than the 15 ºC average at the same time 
point. The empirical predictive model described an exponential increase in the vol-
umetric dispersal rate; an intuitive result, as increasing radial transport orthogonal 
to the point of infusion would cause a cubic rise in infusion volume. As the same 
fluid volume is being infused between each isothermal temperature, suggesting 
that the infusion volume has a lower concentration at higher temperatures as well. 
This implication is an important factor to note if this approach is to be applied to 
slow infusion treatments such as CED.
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This group has previously demonstrated enhanced volu-
metric dispersal of infused contrast agents through concur-
rent photothermal heating [28]. The work described in this 
paper is the first step to developing a comprehensive pre-
dictive model of the in vivo case. The homogeneous agarose 
model enabled empirical predictions through symmetry-
based simplification of a one-dimensional system. While 
these results are limited to the idealized isothermal case, the 
dispersal rate determined for each temperature provides a 
foundation for modeling the asymmetric, spatially variable 
temperatures generated by photothermal heating. As intrace-
rebral treatments are expensive and relatively high risk, ac-
curate pre-intervention simulations should enable clinicians 
to better adapt their approach to speciﬁ c patients and indica-
tions. 
Analysis of the co-delivery infusions correlated well with 
the idealized isothermal case. Quantifying the infusion 
volume’s forward advancement along the beam path exhib-
ited an expected increase of the dispersal rate. The infusion 
volume exhibited a greater forward distribution along the 
beam path, but analysis also indicated that forward progress 
increased orthogonally from the length of the catheter as 
well, but to a lesser degree. This result may be attributable 
to thermal conduction. Standard deviation increased over 
time for both groups, but more markedly for the co-delivery 
infusions. This finding is potentially attributable to small 
differences in local dye concentration caused by the manual 
insertion method, resulting in variation in heat distribution 
throughout the diffusing volume. In an in vivo scenario, the 
high scattering coefﬁ cient of most tissues, including cerebral 
tissues, would much more rapidly reduce the directionality 
of the light and create a more spherical heating volume. How-
ever, the degree to which this effect inﬂ uences heating will 
vary with tissue type and needs to be determined experi-
mentally.  
The isothermal experiment was purposefully designed 
to provide a more simplistic look at the heat-mediated volu-
metric dispersal increase in order to aid in decoupling the 
inﬂ uences of temperature gradients. Ideally, the injected ﬂ uid 
has the same temperature as the agarose, and therefore no 
temperature gradient exists and no natural convection takes 
place. Considering the relatively low injection volume flow 
rate and the fact that the ﬂ uid lines are inserted into the bath 
as well, we can assume that natural convection due to density 
differences of the ﬂ uid in the agarose compound and the in-
jected ﬂ uid is minimized. In the case of the co-delivery infu-
sion, this effect is more complex. Firstly, the localized heating 
changes the permeability, which has a direct inﬂ uence on the 
convection through the porous media. Secondly, the localized 
heating may change the fluid density, which influences the 
ﬂ ow due to buoyancy—especially where the forced convec-
tion is weak. This factor would cause the fluid in the beam 
path to rise toward the needle tip. The fact that we still see 
improved forward distribution indicates that the forced con-
vection counteracts the free convection for the cases studied.
There are many limitations in an agarose phantom’s simu-
lation of living tissue. Agarose’s lack of blood perfusion, iso-
tropic composition, and lack of cellularity are substantially 
different from living tissue. However, 0.6% agarose was es-
tablished by Chen et al. as a reasonable model for cerebral tis-
sue, and has been frequently used in the literature [32, 39, 40]. 
This may represent a very conservative estimate of volume-
tric dispersal variance, as phenomena in living tissue, such 
as blood perfusion, would react synergistically with low-level 
hyperthermia to further increase dispersal of infused ﬂ uid. 
The agarose data provided here correlates well with a previ-
ous in vivo study published by this group wherein sub-lethal 
heating during infusion into rodent brains was shown to 
signiﬁ cantly increase dispersal [28]. The conservation of the 
heat-mediated effects on infusion dispersal volume further 
supports the use of 0.6% agarose as a tissue phantom capable 
of predicting certain in vivo phenomena.
5 Conclusions
This study demonstrated that photothermal heating would 
increase the distribution of infused contrast agents within 
agarose tissue phantoms. The temperature-mediated en-
hancement in volumetric dispersal rate was determined ex-
perimentally through shadowgraphy and image-processing 
techniques. Isothermal infusions were conducted at 15 ºC, 
20 ºC, 25 ºC, and 30ºC. These infusions showed a positive cor-
relation between temperature and Vd, with Vd at 30 ºC show-
ing a 7-fold increase at 100 min over the 15 ºC isothermal case. 
Photothermal co-delivery at 500 mW into room-temperature 
agarose showed a very similar effect with a 3.5-fold increase 
at 4 h over the control (0 mW). These results motivate further 
exploration of the potential role of concurrent photothermal 
heating in enhancing the tissue penetration of chemothera-
peutics and other therapeutic agents. 
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